Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models
出版年份 2019 全文链接
标题
Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-01-30
DOI
10.1002/ijc.32169
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Silence of HDAC6 suppressed esophageal squamous cell carcinoma proliferation and migration by disrupting chaperone function of HSP90
- (2018) Hua Tao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer
- (2018) Jonas Steenbrugge et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting HSP90-HDAC6 Regulating Network Implicates Precision Treatment of Breast Cancer
- (2017) Shiyi Yu et al. International Journal of Biological Sciences
- Combination of a novel HDAC6 inhibitor ACY-241 and anti-PD-L1 antibody enhances anti-tumor immunity and cytotoxicity in multiple myeloma
- (2017) A Ray et al. LEUKEMIA
- ARID1A-mutated ovarian cancers depend on HDAC6 activity
- (2017) Benjamin G. Bitler et al. NATURE CELL BIOLOGY
- Essential role of HDAC6 in the regulation of PD-L1 in melanoma
- (2016) M. Lienlaf et al. Molecular Oncology
- Synthesis and SAR assessment of novel Tubathian analogs in the pursuit of potent and selective HDAC6 inhibitors
- (2016) Rob De Vreese et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma
- (2016) Teru Hideshima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor-environment biomimetics delay peritoneal metastasis formation by deceiving and redirecting disseminated cancer cells
- (2015) Elly De Vlieghere et al. BIOMATERIALS
- Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell death
- (2015) Yuko Mishima et al. BRITISH JOURNAL OF HAEMATOLOGY
- Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
- (2015) K.V. Woan et al. Molecular Oncology
- PTEN activation through K163 acetylation by inhibiting HDAC6 contributes to tumour inhibition
- (2015) Z Meng et al. ONCOGENE
- Creation of a histone deacetylase 6 inhibitor and its biological effects
- (2015) Ju-Hee Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone deacetylase 6 promotes growth of glioblastoma through inhibition of SMAD2 signaling
- (2015) Shun Li et al. TUMOR BIOLOGY
- Histone deacetylase 6 in health and disease
- (2015) Carole Seidel et al. Epigenomics
- HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
- (2015) D. M. Woods et al. Cancer Immunology Research
- The histone deacetylase-6 inhibitor tubacin directly inhibits de novo sphingolipid biosynthesis as an off-target effect
- (2014) Deanna Siow et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- HDAC6 regulates neuroblastoma cell migration and may play a role in the invasion process
- (2014) Linlin Zhang et al. CANCER BIOLOGY & THERAPY
- Histone deacetylase 6 activity is critical for the metastasis of Burkitt’s lymphoma cells
- (2014) Ning Ding et al. Cancer Cell International
- α-Tubulin K40 acetylation is required for contact inhibition of proliferation and cell–substrate adhesion
- (2014) Andrea Aguilar et al. MOLECULAR BIOLOGY OF THE CELL
- A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth
- (2013) M Kaliszczak et al. BRITISH JOURNAL OF CANCER
- Potent and selective HDAC6 inhibitory activity of N-(4-hydroxycarbamoylbenzyl)-1,2,4,9-tetrahydro-3-thia-9-azafluorenes as novel sulfur analogues of Tubastatin A
- (2013) Rob De Vreese et al. CHEMICAL COMMUNICATIONS
- tert-Butylcarbamate-Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells
- (2013) Sergio Valente et al. ChemMedChem
- Induction of differential apoptotic pathways in multiple myeloma cells by class-selective histone deacetylase inhibitors
- (2013) T Hideshima et al. LEUKEMIA
- Histone deacetylase 10 promotes autophagy-mediated cell survival
- (2013) I. Oehme et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
- (2012) L. Santo et al. BLOOD
- ATAT1/MEC-17 acetyltransferase and HDAC6 deacetylase control a balance of acetylation of alpha-tubulin and cortactin and regulate MT1-MMP trafficking and breast tumor cell invasion
- (2012) Antonio Castro-Castro et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Metronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models
- (2012) Christina Hackl et al. GUT
- Depletion of HDAC6 Enhances Cisplatin-Induced DNA Damage and Apoptosis in Non-Small Cell Lung Cancer Cells
- (2012) Lei Wang et al. PLoS One
- Comparative Analysis of Dynamic Cell Viability, Migration and Invasion Assessments by Novel Real-Time Technology and Classic Endpoint Assays
- (2012) Ridha Limame et al. PLoS One
- Second-Generation Histone Deacetylase 6 Inhibitors Enhance the Immunosuppressive Effects of Foxp3+ T-Regulatory Cells
- (2011) Jay H. Kalin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone Deacetylase 6 and Heat Shock Protein 90 Control the Functions of Foxp3+ T-Regulatory Cells
- (2011) E. F. de Zoeten et al. MOLECULAR AND CELLULAR BIOLOGY
- The Role of HDAC6 in Cancer
- (2010) Grace I. Aldana-Masangkay et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
- (2010) Kyle V. Butler et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis
- (2008) Y.-S. Lee et al. CANCER RESEARCH
- Ubiquitin Proteasome System Stress Underlies Synergistic Killing of Ovarian Cancer Cells by Bortezomib and a Novel HDAC6 Inhibitor
- (2008) M. Bazzaro et al. CLINICAL CANCER RESEARCH
- Mice Lacking Histone Deacetylase 6 Have Hyperacetylated Tubulin but Are Viable and Develop Normally
- (2008) Y. Zhang et al. MOLECULAR AND CELLULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started